HRSA Updates Cervical Cancer Screening Guidelines to Include Self-Collection
New guidelines designate high-risk HPV testing as preferred screening method for women ages 30-65 and require insurance coverage for additional testing.
New guidelines designate high-risk HPV testing as preferred screening method for women ages 30-65 and require insurance coverage for additional testing.
AI, new diagnostics, and shifting care delivery models are among the clinical laboratory predictions for 2026.
The collaboration integrates AI-driven blood testing with a nationwide hepatology specialist network to reduce diagnostic delays.
The collaboration aims to unify data systems and automate workflows across pathology laboratories to address operational challenges.
The biotechnology company's integrated screening approach combines whole-genome sequencing, imaging, and multiple biomarker tests to enable early detection.